Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Plus Therapeutics Retained Earnings (Accumulated Deficit) 2010-2024 | PSTV

Plus Therapeutics retained earnings (accumulated deficit) from 2010 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
  
Plus Therapeutics Annual Retained Earnings (Accumulated Deficit)
(Millions of US $)
2024 $-493
2023 $-481
2022 $-467
2021 $-447
2020 $-434
2019 $-425
2018 $-414
2017 $-402
2016 $-379
2015 $-357
2014 $-338
2013 $-301
2012 $-275
2011 $-242
2010 $-210
2009 $-183
Plus Therapeutics Quarterly Retained Earnings (Accumulated Deficit)
(Millions of US $)
2024-12-31 $-493
2024-09-30 $-490
2024-06-30 $-487
2024-03-31 $-484
2023-12-31 $-481
2023-09-30 $-477
2023-06-30 $-473
2023-03-31 $-472
2022-12-31 $-467
2022-09-30 $-462
2022-06-30 $-456
2022-03-31 $-451
2021-12-31 $-447
2021-09-30 $-443
2021-06-30 $-439
2021-03-31 $-436
2020-12-31 $-434
2020-09-30 $-430
2020-06-30 $-428
2020-03-31 $-426
2019-12-31 $-425
2019-09-30 $-426
2019-06-30 $-427
2019-03-31 $-418
2018-12-31 $-414
2018-09-30 $-412
2018-06-30 $-410
2018-03-31 $-406
2017-12-31 $-402
2017-09-30 $-397
2017-06-30 $-393
2017-03-31 $-387
2016-12-31 $-379
2016-09-30 $-374
2016-06-30 $-369
2016-03-31 $-362
2015-12-31 $-357
2015-09-30 $-354
2015-06-30 $-356
2015-03-31 $-360
2014-12-31 $-338
2014-09-30 $-333
2014-06-30 $-323
2014-03-31 $-311
2013-12-31 $-301
2013-09-30 $-291
2013-06-30 $-286
2013-03-31 $-282
2012-12-31 $-275
2012-09-30 $-271
2012-06-30 $-260
2012-03-31 $-252
2011-12-31 $-242
2011-09-30 $-236
2011-06-30 $-227
2011-03-31 $-222
2010-12-31 $-210
2010-09-30 $-201
2010-06-30 $-190
2010-03-31 $-185
2009-12-31 $-183
2009-09-30 $-173
2009-06-30 $-166
2009-03-31 $-165
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.009B $0.006B
Plus Therapeutics Inc. is a clinical-stage pharmaceutical company. It engages in developing treatments for cancer and other diseases primarily in the United States. The company's product candidate consists of DocePLUS which are in clinical stage. Plus Therapeutics Inc., formerly known as Cytori Therapeutics Inc., is based in Austin, Texas.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $98.402B 36.91
Zoetis (ZTS) United States $66.869B 24.90
Daiichi Sankyo, - (DSNKY) Japan $48.872B 24.86
Takeda Pharmaceutical (TAK) Japan $48.269B 10.68
Sandoz Group AG (SDZNY) Switzerland $19.668B 0.00
Merck (MKKGY) Germany $18.191B 15.05
Summit Therapeutics (SMMT) United States $17.973B 0.00
Shionogi (SGIOY) Japan $14.521B 14.55
United Therapeutics (UTHR) United States $13.307B 11.77
Neurocrine Biosciences (NBIX) United States $11.769B 40.31
IPSEN (IPSEY) France $10.376B 0.00
Orion OYJ (ORINY) Finland $9.160B 24.77
Corcept Therapeutics (CORT) United States $7.502B 60.98
Madrigal Pharmaceuticals (MDGL) United States $6.553B 0.00
Stevanato Group S.p.A (STVN) Italy $6.435B 40.87
Ono Pharmaceutical (OPHLF) Japan $5.988B 12.26
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.813B 0.00
Ionis Pharmaceuticals (IONS) United States $5.071B 0.00
Grifols, S.A (GRFS) Spain $4.964B 0.00
Soleno Therapeutics (SLNO) United States $3.679B 0.00
Crinetics Pharmaceuticals (CRNX) United States $2.858B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.812B 11.42
Hypermarcas (HYPMY) Brazil $2.407B 15.83
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.226B 12.17
BioCryst Pharmaceuticals (BCRX) United States $2.149B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.087B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.670B 0.00
Guardian Pharmacy Services (GRDN) United States $1.627B 0.00
Indivior (INDV) United States $1.613B 6.84
Centessa Pharmaceuticals (CNTA) United Kingdom $1.600B 0.00
Evotec AG (EVO) Germany $1.438B 0.00
ARS Pharmaceuticals (SPRY) United States $1.377B 175.25
Ocular Therapeutix (OCUL) United States $1.143B 0.00
Dyne Therapeutics (DYN) United States $1.139B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.110B 45.11
Enliven Therapeutics (ELVN) United States $0.966B 0.00
Ardelyx (ARDX) United States $0.945B 0.00
Harrow (HROW) United States $0.885B 0.00
Collegium Pharmaceutical (COLL) United States $0.869B 4.61
Avadel Pharmaceuticals (AVDL) Ireland $0.835B 0.00
AleAnna (ANNA) United States $0.762B 0.00
Cronos Group (CRON) Canada $0.713B 0.00
Xeris Biopharma Holdings (XERS) United States $0.672B 0.00
Organogenesis (ORGO) United States $0.660B 0.00
KalVista Pharmaceuticals (KALV) United States $0.621B 0.00
Akebia Therapeutics (AKBA) United States $0.607B 0.00
Xencor (XNCR) United States $0.602B 0.00
Relay Therapeutics (RLAY) United States $0.540B 0.00
USANA Health Sciences (USNA) United States $0.537B 11.53
Regulus Therapeutics (RGLS) United States $0.519B 0.00
Savara (SVRA) United States $0.518B 0.00
Bioventus (BVS) United States $0.508B 12.92
Theravance Biopharma (TBPH) Cayman Islands $0.505B 0.00
CytoDyn (CYDY) United States $0.483B 0.00
Elite Pharmaceuticals (ELTP) United States $0.447B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.414B 0.00
Zevra Therapeutics (ZVRA) United States $0.405B 0.00
Verve Therapeutics (VERV) United States $0.389B 0.00
Altimmune (ALT) United States $0.387B 0.00
Siga Technologies (SIGA) United States $0.376B 6.43
Tourmaline Bio (TRML) United States $0.373B 0.00
Heron Therapeutics (HRTX) United States $0.369B 0.00
Oruka Therapeutics (ORKA) United States $0.348B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.326B 8.82
Aquestive Therapeutics (AQST) United States $0.267B 0.00
Avita Medical (RCEL) United States $0.243B 0.00
Wellgistics Health (WGRX) United States $0.236B 0.00
Nature's Sunshine Products (NATR) United States $0.229B 21.03
ProKidney (PROK) United States $0.202B 0.00
Esperion Therapeutics (ESPR) United States $0.193B 0.00
MediWound (MDWD) Israel $0.192B 0.00
OmniAb (OABI) United States $0.189B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.164B 0.00
Nanobiotix S.A (NBTX) France $0.160B 0.00
Journey Medical (DERM) United States $0.150B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.150B 46.35
Profound Medical (PROF) Canada $0.149B 0.00
Inhibikase Therapeutics (IKT) United States $0.144B 0.00
4D Molecular Therapeutics (FDMT) United States $0.143B 0.00
Korro Bio (KRRO) United States $0.139B 0.00
Aclaris Therapeutics (ACRS) United States $0.139B 0.00
Larimar Therapeutics (LRMR) United States $0.134B 0.00
Protara Therapeutics (TARA) United States $0.130B 0.00
Aldeyra Therapeutics (ALDX) United States $0.126B 0.00
Lyell Immunopharma (LYEL) United States $0.123B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.121B 0.00
Nektar Therapeutics (NKTR) United States $0.119B 0.00
Lexeo Therapeutics (LXEO) United States $0.108B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.108B 0.00
OptiNose (OPTN) United States $0.095B 0.00
Cardiol Therapeutics (CRDL) Canada $0.088B 0.00
VAXART, INC (VXRT) United States $0.086B 0.00
Galectin Therapeutics (GALT) United States $0.086B 0.00
Achieve Life Sciences (ACHV) Canada $0.086B 0.00
Arch Biopartners (ACHFF) Canada $0.083B 0.00
Champions Oncology (CSBR) United States $0.081B 13.27
Dominari Holdings (DOMH) United States $0.077B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.076B 0.00
ESSA Pharma (EPIX) Canada $0.076B 0.00
Telomir Pharmaceuticals (TELO) United States $0.075B 0.00
Fractyl Health (GUTS) United States $0.073B 0.00
Cassava Sciences (SAVA) United States $0.073B 0.00
Unicycive Therapeutics (UNCY) United States $0.073B 0.00
Context Therapeutics (CNTX) United States $0.072B 0.00
Nutriband (NTRB) United States $0.067B 0.00
Pyxis Oncology (PYXS) United States $0.066B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.062B 49.00
Vivani Medical (VANI) United States $0.061B 0.00
Inotiv (NOTV) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Assertio Holdings (ASRT) United States $0.058B 0.00
Gain Therapeutics (GANX) United States $0.056B 0.00
Metagenomi (MGX) United States $0.054B 0.00
Karyopharm Therapeutics (KPTI) United States $0.054B 0.00
Avalo Therapeutics (AVTX) United States $0.052B 0.00
ElectroCore (ECOR) United States $0.050B 0.00
Century Therapeutics (IPSC) United States $0.046B 0.00
PMV Pharmaceuticals (PMVP) United States $0.045B 0.00
Mural Oncology (MURA) Ireland $0.043B 0.00
Acrivon Therapeutics (ACRV) United States $0.042B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.042B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.037B 0.00
SCYNEXIS (SCYX) United States $0.037B 0.00
Iterum Therapeutics (ITRM) Ireland $0.036B 0.00
Prelude Therapeutics (PRLD) United States $0.035B 0.00
Rafael Holdings (RFL) United States $0.034B 0.00
NRx Pharmaceuticals (NRXP) United States $0.033B 0.00
Surrozen (SRZN) United States $0.032B 0.00
FibroGen (FGEN) United States $0.029B 0.00
PolyPid (PYPD) Israel $0.028B 0.00
Enlivex Therapeutics (ENLV) Israel $0.026B 0.00
Tempest Therapeutics (TPST) United States $0.024B 0.00
CASI Pharmaceuticals (CASI) China $0.022B 0.00
BioVie (BIVI) United States $0.021B 0.00
VYNE Therapeutics (VYNE) United States $0.021B 0.00
Jupiter Neurosciences (JUNS) United States $0.020B 0.00
Mannatech (MTEX) United States $0.019B 7.60
DURECT (DRRX) United States $0.018B 0.00
Lipocine (LPCN) United States $0.018B 0.00
Natural Alternatives (NAII) United States $0.017B 0.00
TherapeuticsMD (TXMD) United States $0.016B 0.00
GlycoMimetics (GLYC) United States $0.016B 0.00
Vivos Therapeutics (VVOS) United States $0.015B 0.00
MEI Pharma (MEIP) United States $0.014B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.013B 0.00
Cosmos Health (COSM) United States $0.012B 0.00
Relmada Therapeutics (RLMD) United States $0.012B 0.00
Scienture Holdings (SCNX) United States $0.011B 0.00
ProPhase Labs (PRPH) United States $0.011B 0.00
Minerva Neurosciences (NERV) United States $0.011B 8.47
Talphera (TLPH) United States $0.011B 0.00
BioLineRx (BLRX) Israel $0.011B 0.00
Ernexa Therapeutics (ERNA) United States $0.011B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 3.17
Carisma Therapeutics (CARM) United States $0.009B 0.00
Mangoceuticals (MGRX) United States $0.009B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Ainos (AIMD) United States $0.008B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
Phio Pharmaceuticals (PHIO) United States $0.008B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.008B 0.00
Nuvilex (PMCB) United States $0.008B 0.00
Jaguar Animal Health (JAGX) United States $0.007B 0.00
Citius Pharmaceuticals (CTXR) United States $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.007B 0.00
Lyra Therapeutics (LYRA) United States $0.007B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.006B 0.00
Conduit Pharmaceuticals (CDT) United States $0.005B 0.00
Klotho Neurosciences (KLTO) United States $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Incannex Healthcare (IXHL) Australia $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
SHINECO (SISI) China $0.001B 0.00
Heatwurx (PCSA) United States $0.001B 0.00
Petros Pharmaceuticals (PTPI) United States $0.000B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Aditxt (ADTX) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00